These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8540856)
21. Clinical aspects and prognosis of mixed microbial (bacterial and fungal) keratitis. Ahn M; Yoon KC; Ryu SK; Cho NC; You IC Cornea; 2011 Apr; 30(4):409-13. PubMed ID: 21045645 [TBL] [Abstract][Full Text] [Related]
22. Microbial keratitis secondary to infection with Citrobacter koseri. Goold LA; Warrier SK; Wittles NK; Nathan F Cornea; 2010 Apr; 29(4):479. PubMed ID: 20164753 [No Abstract] [Full Text] [Related]
23. Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states. Hsu HY; Nacke R; Song JC; Yoo SH; Alfonso EC; Israel HA Eye Contact Lens; 2010 Jul; 36(4):195-200. PubMed ID: 20626115 [TBL] [Abstract][Full Text] [Related]
24. Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis. Kaye S; Tuft S; Neal T; Tole D; Leeming J; Figueiredo F; Armstrong M; McDonnell P; Tullo A; Parry C Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):362-8. PubMed ID: 19684005 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256 [TBL] [Abstract][Full Text] [Related]
26. Problems with monotherapy for bacterial keratitis. Guzek JP Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6902-3; author reply 6903. PubMed ID: 21123792 [No Abstract] [Full Text] [Related]
27. Diagnostic and therapeutic challenges in a case of amikacin-resistant Nocardia keratitis. Johansson B; Fagerholm P; Petranyi G; Claesson Armitage M; Lagali N Acta Ophthalmol; 2017 Feb; 95(1):103-105. PubMed ID: 27572657 [No Abstract] [Full Text] [Related]
28. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580 [TBL] [Abstract][Full Text] [Related]
29. The role of cultures in the management of ulcerative keratitis. Levey SB; Katz HR; Abrams DA; Hirschbein MJ; Marsh MJ Cornea; 1997 Jul; 16(4):383-6. PubMed ID: 9220233 [TBL] [Abstract][Full Text] [Related]
33. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group. Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124 [TBL] [Abstract][Full Text] [Related]
34. Acute Corneal Hydrops Complicated by Microbial Keratitis: Case Series Reveals Poor Immediate and Long-Term Prognosis. Meyer JJ; McGhee CN Cornea; 2016 Jul; 35(7):1019-22. PubMed ID: 27191669 [TBL] [Abstract][Full Text] [Related]
35. Controversies in management of bacterial keratitis. Charukamnoetkanok P; Pineda R Int Ophthalmol Clin; 2005; 45(4):199-210. PubMed ID: 16199977 [No Abstract] [Full Text] [Related]
36. Infectious keratitis after photorefractive keratectomy in the United States army and navy. Wroblewski KJ; Pasternak JF; Bower KS; Schallhorn SC; Hubickey WJ; Harrison CE; Torres MF; Barnes SD Ophthalmology; 2006 Apr; 113(4):520-5. PubMed ID: 16488012 [TBL] [Abstract][Full Text] [Related]